Introduction
It is vitally important that cells with damaged DNA do not attempt cell division, since the daughters risk mutation or permanent loss of genetic information. In many eukaryotes, including fission yeast and vertebrate cells, division with damage is prevented through the action of a cell cycle checkpoint mechanism which delays the onset of mitosis and extends the duration of the G 2 phase (often referred to as the G 2 /M checkpoint; O'Connell et al., 2000) . It is generally believed that mitotic delay provides cells with additional time to repair damaged DNA in G 2 and, if successful, to subsequently enter mitosis and segregate the repaired genome normally.
In recent years, the molecular basis of the G 2 /M checkpoint has been elucidated in some detail both in fission yeast and vertebrate cells (O'Connell et al., 2000) . The presence of DNA damage in each case is detected by a variety of conserved sensor molecules leading to the activation of the upstream protein kinases, ataxia telangiectasia mutated/ataxia telangiectasia and Rad3 related ATM/ATR (in vertebrates) or Rad3 (fission yeast). ATM and ATR (or Rad3) in turn phosphorylate and activate the checkpoint effector kinases Chk1 and Chk2 (Cds1 in fission yeast), which then implement specific checkpoint responses by acting on downstream substrates (O'Connell et al., 2000) . In fission yeast, the checkpoint effector kinases are activated by different signals and dedicated to distinct tasks; whereas Chk1 is selectively activated by DNA damage and responsible for G 2 /M arrest, Cds1 is selectively activated in response to DNA synthesis inhibition and required both to delay mitosis and for a variety of other replication checkpoint responses needed in S-phase cells (O'Connell et al., 2000; Chen and Sanchez, 2004) . When activated, Chk1 and Cds1 are thought to delay mitosis at least in part by phosphorylating and inhibiting the Cdc25 phosphatase which normally activates the cyclin-dependent kinase, Cdk1, at the onset of mitosis by removing inhibitory tyrosine phosphorylation (O'Connell et al., 2000) .
The situation in vertebrate cells appears to be rather different, both in terms of the division of labour between Chk1 and Chk2 and in their patterns of regulation. In vertebrates, Chk1 is activated both in response to DNA damage and DNA synthesis inhibition, most probably by ATR, and appears to be the principal effector of both G 2 /M arrest and the replication checkpoint functions (Bartek and Lukas, 2003; Chen and Sanchez, 2004) . In marked contrast to Cds1 in fission yeast, Chk2 is also efficiently activated by DNA damage in vertebrate cells via direct phosphorylation by ATM (Matsuoka et al., 1998; Ahn et al., 2000) . Chk1 and Chk2 are however differentially regulated during the cell cycle; whereas Chk2 activation by DNA damage can occur during all phases of the cell cycle and in quiescent cells (Lukas et al., 2001) , activation of Chk1 is confined to the S and G 2 phases of proliferating cells (Jazayeri et al., 2006) .
Genetic evidence in humans suggests that Chk2 may act as tumour suppressor. Specifically, germ-line mutations in Chk2 are thought to act as low-penetrance predisposition alleles in breast and possibly other cancer types (Nevanlinna and Bartek, 2006) , and in a small subset of Li-Fraumeni or Li-Fraumeni-like syndrome kindreds (Bell et al., 1999) . In addition, somatic mutations affecting Chk2 occur sporadically at low frequency in various human tumour types (Miller et al., 2002) . At present, the molecular basis for tumour suppression by Chk2 in humans is unclear. There is evidence that Chk2 is an upstream regulator of p53 (Matsuoka et al., 1998; Hirao et al., 2000) , and this regulation appears to be important for DNA damageinduced apoptosis in some (Hirao et al., 2002; Takai et al., 2002) , although not all (Jallepalli et al., 2003) , cell types. Chk2 inactivation might therefore favour tumorigenesis by attenuating p53-dependent apoptosis in incipient cancer cells (Cao et al., 2006) . Alternatively, loss of Chk2 function might predispose to carcinogenesis by promoting genome instability and mutation as a result of defects in one or more cell cycle checkpoint responses (Bartkova et al., 2005) .
The G 2 /M checkpoint is crucial for genome stability because it protects against division with damage. Recently the mechanism of this response in vertebrate cells has been found to be more complex than hitherto believed. Specifically, it has been shown that the precise nature of the G 2 /M arrest induced by DNA damage varies according to a cell's position in the cell cycle at the time when damage is incurred (Xu et al., 2002) . Cells that sustain damage in G 1 or S phase experience a prolonged mitotic delay on reaching G 2 that may last for many hours. Typically, this arrested population builds steadily with time after damage as cells progress to G 2 , reaches a peak and then declines. This behaviour has been termed 'G 2 accumulation', and can be monitored readily by DNA content flow cytometry (Xu et al., 2002) . By contrast, cells that are in G 2 at the time of damage must arrest more rapidly and this 'immediate' G 2 delay is typically of much shorter duration (Xu et al., 2002) . Importantly, this latter population can only be studied using methods which distinguish unambiguously between G 2 and mitotic cells (Xu et al., 2002) . In addition to differing in duration, these responses appear to be functionally distinct in other ways. For example, G 2 accumulation after radiation-induced DNA damage has been shown to be dose dependent but ATM independent whereas conversely, immediate mitotic delay in G 2 cells is ATM dependent but relatively dose independent (Xu et al., 2002) .
A wealth of biochemical and genetic evidence has established Chk1 as an important effector of G 2 /M checkpoint arrest after DNA damage in vertebrate cells (Bartek and Lukas, 2003; Chen and Sanchez, 2004) , however whether Chk2 also contributes to this response has been controversial. Early studies using Chk2-deficient mouse ES cells suggested that Chk2 was required to maintain but not to initiate G 2 /M arrest in response to ionizing radiation (IR) (Matsuoka et al., 1998) . This defect, however, was not observed in Chk2-deficient mouse embryo fibroblasts, where mitotic delay after irradiation appeared normal although G 1 /S arrest was impaired (Takai et al., 2002) . Similarly, Chk2 inhibition by various strategies has been observed to inhibit DNA damage-induced G 2 /M arrest in some (Yu et al., 2001) but not all cell lines in culture (Jallepalli et al., 2003) .
Variations in cell type and experimental conditions may account for some of these apparent discrepancies, however we considered that the inherent complexity of G 2 /M checkpoint responses could be another important factor. To evaluate this possibility further, we have generated Chk2-deficient DT40 B-lymphoma cells by gene targeting and compared their G 2 /M checkpoint proficiency in response to IR with wild-type (WT) and an isogenic Chk1-deficient derivative (Zachos et al., 2003) . We show that G 2 accumulation occurs normally in the absence of Chk2, however the immediate mitotic delay triggered by DNA damage in G 2 cells is significantly impaired. As a result, Chk2-deficient cells enter mitosis bearing DNA damage lesions immediately after irradiation more readily than WT. Impaired G 2 delay in Chk2-deficient cells can be detected at very low doses of radiation (0.1 Gy), and may allow division with spontaneous DNA damage, since a higher proportion of mitotic Chk2À/À cells bear spontaneous g-H2AX foci and damaged chromosomes during unperturbed growth compared to WT. We suggest that this function of Chk2 could contribute to tumour suppression, since cell division with low levels of spontaneous damage is likely to promote genetic instability and thus carcinogenesis.
Results and discussion
Characterization of avian Chk2 and generation of Chk2-deficient DT40 cells To investigate the role of Chk2 in cell cycle checkpoint responses we generated Chk2-deficient DT40 cells by gene targeting. Automated computational (GNOMON) analysis of the chicken genome predicts an avian Chk2 homologue of 589 amino acids (accession number XP_415205), however only part of this sequence is similar to human and mouse Chk2 proteins (not shown). We therefore isolated a natural Chk2 cDNA from a chicken B-cell cDNA library (see 'Materials and methods' for details). The sequence of this cDNA predicts an avian Chk2 protein of 522 amino acids with similarity to Chk2 homologues from other species throughout its length (accession number EF118300). As shown in Figure 1a , the overall sequence and organization of the kinase domain (blue), forkheadassociated (FHA) domain (orange) and serine-glutamine (SQ) cluster motif (yellow) are highly conserved between chicken Chk2 and the human, mouse and frog homologues. A potential regulatory ATM phosphorylation site within the SQ motif (corresponding to threonine 68 (T68) in human Chk2; highlighted in mauve) together with two potential autophosphorylation sites within the activation loop of the kinase domain (highlighted in green) is also conserved in the avian protein.
Targeting vectors designed to delete the Chk2 FHA and kinase domains were then constructed and used to sequentially disrupt both alleles of Chk2 in DT40 cells by homologous recombination as described previously for Chk1 (Zachos et al., 2003) . After two rounds of targeting (see 'Materials and methods' for details), a Chk2 nullizygous cell line was identified by Southern blotting and confirmed to be devoid of Chk2 mRNA and protein expression by reverse transcription (RT)-PCR and western blotting respectively (Figures 1b and c). The doubling time of the Chk2À/À DT40 cultures was estimated at 12 h compared to 10 h for WT, however this did not appear to be attributable to an increase in the incidence of cell death as observed previously in Chk1À/À cultures (Zachos et al., 2003) . In several independent growth comparison experiments we did not observe any excess of apoptotic cells in Chk2À/ À cell cultures compared to WT as judged by Annexin V staining, while 5-bromo-2-deoxyuridine pulse-chase analysis revealed an increase in overall cell cycle transit time consistent with the slower doubling time (data not shown).
Chk2 is activated by DNA damage but not replication arrest in DT40 cells Activation of human and mouse Chk2 protein in response to DNA damage requires phosphorylation of Analysis of Chk2 mRNA (left) and protein expression (right) in WT DT40 cells and in hemizygous and nullizygous Chk2 disruptants identified by Southern blotting after one and two rounds of gene targeting respectively. Chk2 mRNA was detected by RT-PCR using primers specific for Chk1 as a positive control, while Chk2 protein was detected using an antiserum generated against a synthetic peptide corresponding to the C terminus of avian Chk2.
T68 within the SQ motif catalysed by ATM (Ahn et al., 2000) . T68 is conserved in avian Chk2 (Figure 1a ), however the surrounding amino acid sequence differs sufficiently to preclude recognition by commercial antibodies specific for human or mouse Chk2 phosphorylated at this site (M Rainey, unpublished results). Chk2 activation however is also associated with a pronounced electrophoretic mobility shift which can be detected using non-discriminating antibodies (Ahn et al., 2000) . As shown in Figure 2 (upper panel), when WT cells were exposed to 4 Gy of IR most or all of the Chk2 protein was activated within 30-60 min, as judged by conversion into a more slowly migrating phosphorylated isoform, followed by gradual reappearance of the more rapidly migrating inactive form at later times. Similar results were observed with the DNA-damaging agent etoposide, although in this case Chk2 activation occurred more slowly and persisted at maximal levels throughout the course of the treatment (Figure 2 , middle panel). In contrast, when cells were treated with the DNA polymerase inhibitor aphidicolin little, if any, activation of Chk2 was detected (Figure 2 , lower panel). Taken together, these results are consistent with observations in other cell types (McGowan, 2002) and indicate that in DT40 cells Chk2 is activated strongly in response to DNA damage but weakly if at all by DNA synthesis inhibition. Furthermore, the finding that Chk2 is rapidly and quantitatively activated after irradiation of an asynchronous culture (at least at 4 Gy) implies that activation in response to DNA damage occurs in all phases of the cell cycle.
Chk2 is dispensable for G 2 accumulation at late times after irradiation To investigate the possible role of Chk2 in DNA damage-induced G 2 /M arrest, we first compared the effect of irradiation on the cell cycle distribution of WT and Chk2À/À cells over time using DNA content flow cytometry. DT40 cells have lost p53 function and consequently lack an effective G 1 /S checkpoint (Takao et al., 1999) . As shown in Figure 3 , exposure to 4 Gy of IR resulted in a progressive accumulation of WT cells in G 2 phase, which peaked around 10 h (asterisk) with a subsequent decline at later times. A similar G 2 accumulation was observed after irradiation of Chk2À/À cultures, although the peak occurred at 12 h (asterisk), presumably reflecting their somewhat slower division rate. There was furthermore little if any difference in the degree to which G 2 accumulation was induced in Chk2À/À cells compared to WT after exposure to a range of radiation doses from 2 to 20 Gy (Figure 3b ). In comparison, Chk1À/À cells exhibited no measurable G 2 accumulation at any radiation dose tested (Figures 3b and 4a ; Zachos et al., 2003) .
Chk2 is required for optimal immediate mitotic delay in cells that incur damage in G 2
These results demonstrated that Chk2 was dispensable for G 2 accumulation at late times after irradiation, however this arrested population has previously been shown to be formed primarily from cells which were in G 1 or S phase at the time of irradiation (Xu et al., 2002) . To monitor the fate of that subset of cells that were in G 2 at the time of damage, we used 'nocodazole trapping'. By disrupting microtubules nocodazole traps cells in mitosis, thereby allowing the rate at which cells enter this phase from G 2 to be quantified by flow cytometry (Xu et al., 2002) . During the first few hours of nocodazole treatment most or all of the cells trapped in mitosis will have been in G 2 phase when drug was added, therefore this assay initially documents the efficacy of G 2 arrest specifically in this population (Xu et al., 2002) .
To investigate the possible requirement for Chk2 to delay mitosis in G 2 , asynchronous cultures of WT, Chk2À/À and Chk1À/À cells were treated with nocodazole with or without prior exposure to 4 Gy of IR \and the accumulation of mitotic cells quantified over 4 h. The absolute values for each culture are shown in Figures 4a-c, in Figure 4d the data are presented as the ratio of irradiated/control at each time point to give a cumulative measure of how many cells of each genotype delayed entry to mitosis after irradiation (Xu et al., 2002) .
As shown in Figure 4a , irradiation failed to induce any measurable mitotic delay in cells devoid of Chk1 using this assay, resulting in an irradiated/control ratio of B1 throughout the course of the experiment (Figure 4d ; blue line). In WT cells, by contrast, the proportion of mitotic cells in the damaged sample was diminished to B0.7 compared to control immediately after irradiation (Figure 4d , black line), indicating that a significant number of cells had already arrested in G 2 during the 10 min needed to administer 4 Gy. This ratio then declined still further after 1 and 2 h, when mitotic accumulation was completely blocked in the irradiated culture, before recovering modestly at 4 h as mitotic entry resumed (Figures 4b and d) .
In striking contrast, although irradiation did slow the rate of mitotic accumulation in Chk2À/À cells (Figure 4c ), many more mitotic cells were trapped in the damaged population compared to control than in WT cultures as judged by higher irradiated/control ratios at each time point (Figure 4d , red line), indicating that the proficiency of immediate G 2 arrest was compromised. Interestingly, this impairment was equally evident 1 h after irradiation with 2 and 0.5 Gy and remained detectable even at doses as low as 0.1 Gy (Figure 5 ).
Importantly, doses of IR lower than 1 Gy are ineffective at inducing G 2 accumulation at later times in DT40 cells (data not shown). Taken together, these data indicate that Chk2 is required for efficient immediate mitotic delay in response to radiation-induced DNA damage incurred specifically in G 2 phase but not at earlier phases of the cell cycle. Furthermore, the requirement for Chk2 in immediate mitotic delay is evident at low doses of radiation that are insufficient to induce G 2 accumulation at later times.
We also investigated the extent to which Chk1 and Chk2 were activated 1 h after various doses of irradiation and monitored the levels of Cdc25A, a downstream target of checkpoint signalling which can be degraded in response to DNA damage (Sorensen et al., 2003) . Perhaps surprisingly, at radiation doses below 2 Gy there was little or no activation of Chk2 in WT cells as judged by the appearance of the slower migrating phosphorylated isoform, nor was activatory phosphorylation of Chk1 at serine 345 (pS345) significantly induced in either WT or Chk2À/À cells (Figures 5b  and c) . Similarly, Cdc25A levels were significantly decreased only after irradiation with 2 Gy or more (Figure 5c ). We conclude that low levels of radiationinduced DNA damage can induce significant immediate G 2 delays (Figure 5a ) in the absence of overt activation of conventional biochemical markers of checkpoint activation, presumably because signalling is either very transient or confined to a small subset of cells in the population and thus below the limits of detection in such assays.
Loss of Chk2 allows mitotic entry with DNA damage after irradiation
Mitotic delay is widely believed to provide time for DNA damage to be repaired before the onset of mitosis (Sancar et al., 2004) . We therefore considered that the impaired ability of Chk2À/À cells to delay mitotic entry after irradiation might permit cells with damaged DNA to enter mitosis. To evaluate this possibility, we exposed cultures of WT and Chk2À/À cells to 4 Gy of IR (without nocodazole treatment) and collected samples either immediately or after 0.5, 1, and 2 h. Cells were fixed and stained with antibodies specific for histone H3 phosphorylated at serine 10 (pH3) to identify mitotic cells (visualized in red), and for histone H2AX phosphorylated at serine 139 (g-H2AX) to identify DNA damage foci (visualized in green) and analysed by confocal microscopy (Figure 6c ). pH3-positive mitotic cells were then scored for the presence of g-H2AX foci.
In Figures 6a and b , the proportion of both total pH3-positive mitotic cells and pH3-positive/g-H2AX double-positive damaged mitotic cells is presented as a percentage of total cells. Representative examples of pH3-positive mitotic cells scored as either lacking (control) or bearing multiple g-H2AX foci are shown in Figure 6c . g-H2AX staining of the spindle poles or centrosomes of unirradiated cells was often observed in both genotypes (Figure 6c , asterisks in control panel), however this was readily distinguished from the radiation-induced foci associated with condensed chromosomes (Figure 6c , arrows in þ IR 0 h panel).
As shown in Figure 6a and b, immediately after irradiation ( þ IR 0 h) essentially all of the pH3-positive, mitotic cells in both WT and Chk2À/À cultures exhibited numerous prominent g-H2AX foci, indicative of high levels of DNA damage. Most of these cells are likely to have been in mitosis at the time of damage, which is of approximately 45 min in duration in DT40 cells (data not shown). In WT cultures, the number of both total and damaged mitotic cells then declined in parallel with approximately one-third remaining after 30 min and virtually none by 1 h. We believe that this rapid emptying of the mitotic compartment reflects the fact that DNA damage incurred in mitosis does not delay mitotic exit in DT40 cells as reported in other cells (Skoufias et al., 2004 ; data not shown), and that mitotic entry from G 2 is blocked completely for 2 h in WT cells after irradiation at this dose (Figure 4b) . In marked contrast, the overall percentage of pH3-positive cells was maintained at higher levels at each time point after irradiation of Chk2À/À cultures (Figure 6b ), consistent with the higher level of mitotic entry documented by nocodazole trapping (Figure 4) . Importantly, even after 2 h all of the mitotic Chk2À/À cells continued to bear numerous g-H2AX foci (Figure 6c ). Taken together, these results suggest that Chk2 is required to prevent a subset of G 2 cells with DNA damage from entering mitosis after irradiation.
Loss of Chk2 function predisposes to division with damage and chromosome aberrations during unperturbed growth Mitotic cells bearing g-H2AX foci were not observed in unirradiated WT (control) cultures in the experiment described above (Figure 6a ), however a subset of unirradiated mitotic Chk2À/À cells did (Figure 6b ). This suggested that Chk2 might play a role in delaying the onset of mitosis in cells with low levels of spontaneous DNA damage. To evaluate this possibility more rigorously, cells from three independent cultures of WT and Chk2À/À cells in exponential growth phase were fixed and the percentage of mitotic cells bearing one or more g-H2AX foci determined. As shown in Figure 7a , the basal level of mitotic cells bearing damage foci was approximately threefold higher in Chk2À/À cells compared to WT. To confirm that this increase was specifically attributable to inactivation of Chk2, we generated a revertant cell line by stable re-introduction of an avian Chk2 cDNA into the parental nullizygous cells. This cell line, designated Chk2Rev2, expresses Chk2 at close to physiological levels as determined by western blotting (Figure 7b) . Importantly, the percentage of mitotic cells bearing g-H2AX foci was reduced to almost WT levels in Chk2Rev2 cells, indicating that re-introduction of Chk2 suppresses mitotic entry with damage.
g-H2AX focus formation is widely accepted as a surrogate marker of DNA damage lesions, however to confirm that this was in fact a reliable indicator of genetic damage, we also evaluated the effect of Chk2 inactivation of the frequency of spontaneous cytological chromosome aberrations. Asynchronous cultures of WT, Chk2À/À and Chk2Rev2 cells were treated with colcemid for 3 h and metaphase spreads prepared and scored by light microscopy for isochromatid breaks and gaps affecting macrochromosomes as described previously (Sonoda et al., 1998) . An example of a Chk2À/À metaphase with an isochromatid break is shown in Figure 7d . This analysis revealed that the incidence of metaphase spreads exhibiting physical chromosomal aberrations was approximately sevenfold higher in Chk2À/À cells compared to WT (Figure 7c ). As with g-H2AX foci, this elevated level was again substantially reduced in Chk2Rev2 cells. Thus, loss of Chk2 increases the frequency at which cells enter mitosis bearing spontaneous DNA damage lesions marked by g-H2AX and physically damaged chromosomes during unperturbed growth. 
Conclusions
These findings raise a number of important questions. First, why is Chk2 required for optimal mitotic delay specifically in cells that sustain irradiation-induced DNA damage specifically in G 2 but not in earlier phases of the cell cycle? We suspect that this may relate to recent findings that Chk1 and Chk2 are differentially regulated in response to DNA damage during the cell cycle (Jazayeri et al., 2006) . Whereas Chk2 can be activated in all phases of the cell cycle (with the possible exception of mitosis), activation of Chk1 by DNA damage is confined to the S and G 2 phases and does not occur in G 1 (Figure 8 ). This may explain why the DNA damage-activated G 1 /S checkpoint is compromised in cells lacking Chk2 (Takai et al., 2002) . It is also logical to expect that after the responsive period during S and G 2 , Chk1 must subsequently become refractory to activation by DNA damage at some point before a cycling cell returns to G 1 (Figure 8 ). If this point precedes the onset of mitosis in late G 2 , it is possible to predict a transition period during which Chk1 could no longer be activated in response to DNA damage but Chk2 would (Figure 8 ). In fact, there is evidence that Chk1 is refractory to ATR-mediated phosphorylation and activation by DNA damage in mitotic cells (Shiromizu et al., 2006) , possibly owing to cell cycle phase-specific degradation of the adaptor protein Claspin (Mailand et al., 2006; Peschiaroli et al., 2006) , therefore it is highly plausible that the transition precedes the onset of this phase. We hypothesize that during this transition period Chk2 becomes increasingly, and ultimately solely, responsible for G 2 delay in response to damage in cells which are imminently about to enter mitosis (Figure 8) .
What might be the biological rationale for this scenario? We note that previous studies have shown that immediate G 2 delay can be triggered effectively at very low doses of radiation, whereas G 2 accumulation is markedly dose dependent (Xu et al., 2002) . Similarly, our own findings show that Chk2's contribution to immediate G 2 delay is detectable at very low levels of damage ( Figure 5) . The need for G 2 delay in response to low levels of damage is of course particularly acute in cells which are imminently about to enter mitosis, whereas cells in earlier stages of the cell cycle are likely to be able to repair such lesions before reaching that critical point. We therefore suggest a model in which the role of Chk2 is to provide an auxiliary mitotic delay mechanism which is sensitive to very low levels of DNA damage and remains operative in late G 2 at a time when Chk1 is refractory to activation (Figure 8 ). Our results also suggest that one important function of this mechanism is to restrain, presumably temporarily, mitotic entry in cells which bear low levels of spontaneous DNA damage during otherwise unperturbed growth. Loss of Chk2 would therefore be predicted to result in increased levels of spontaneous mutation and genome instability, consequences that could contribute to its function as a tumour suppressor.
Materials and methods
Isolation of an avian Chk2 cDNA and generation of Chk2-deficient and Chk2-revertant cells An avian B cell cDNA library (Stratagene, Gebouw California, Amsterdam, Netherlands) was screened using a human Chk2 cDNA probe and a full-length avian Chk2 cDNA isolated and sequenced on both DNA strands. The sequence of this cDNA has been deposited in GenBank (accession number EF118300). To construct the targeting vectors, oligonucleotide primers designed from the sequence of this cDNA were used to PCR amplify segments of the genomic Chk2 locus using DT40 DNA as a template. The sequence of the PCR primers is available on request. Two separate targeting vectors containing a common 1.0 kb left and 3.5 kb right arm of homology were synthesized by long-range PCR and cloned into Bluescript (Stratagene) flanking either neomycin or puromycin drug selection cassettes (Sonoda et al., 1998) . The targeting constructs were designed to delete both the Chk2 FHA and kinase domains so that any residual truncated polypeptide encoded by the targeted alleles would be non-functional.
To generate Chk2-deficient DT40 clones, two rounds of targeting were performed to disrupt both Chk2 alleles using initially PCR and subsequently Southern blotting to genotype drug-resistant clones. Cells were electroporated with the neomycin-targeting vector using a Gene Pulser (BioRad Laboratories Ltd, Hemel-Hempstead, UK) at 300 V and 960 mF and drug-resistant clones selected in 1.2 mg/ml G418 (Sigma-Aldrich Company Ltd, Poole, UK) to obtain hemizygous Chk2 þ /Àcells. One hemizygous clone was then electroporated with the puromycin-targeting vector and selected in 0.4 mg/ml puromycin (Sigma) to obtain a nullizygous clone. To generate the revertant cell line, Chk2À/À cells were transfected with an expression vector encoding avian Chk2 (pcDNA3.1zeo, Invitrogen Ltd, Paisley, UK) and selected in 30 mg/ml zeocin (Invitrogen Ltd, Paisley, UK). Drug-resistant clones were screened for Chk2 expression by western blotting and a cell line with near normal levels of Chk2 identified and designated Chk2Rev2. Cell culture and treatments DT40 B-lymphoma cells were grown in Dulbecco's modified Eagle's medium (Gibco/Invitrogen Ltd) containing 10% fetal bovine serum, 1% chicken serum, 10 À5 M b-mercaptoethanol, penicillin, streptomycin, at 39.51C. Cells were irradiated with 0.1-20 Gy of g-radiation using an Alcyon II CGR MeV Cobalt source and treated with1 mg/ml nocodazole (Sigma) as appropriate.
Western blotting A polyclonal rabbit antiserum specific for avian Chk2 was generated using a synthetic peptide corresponding to the C-terminal 15 amino acids of chicken Chk2 conjugated to keyhole limpet haemocyanin. Cell extracts were prepared, resolved by sodium dodecyl sulphate-polyacrylamide gel electrophoresis, and analysed by western blotting as described previously (Zachos et al., 2003) . Antibodies against total and S345-phosphorylated Chk1 were from Santa Cruz Biotechnology (Heidelberg, Germany) (G4) and New England Biolabs Ltd (Hitchin, UK) respectively, while antiserum specific for Cdc25A was from Santa Cruz Biotechnology (sc-7157).
Flow cytometry
Cells were fixed in 70% ethanol in phosphate-buffered saline (PBS) overnight. For DNA content analysis cells were pelleted and resuspended in PBS containing 1 mg/ml RNase (Qiagen Ltd, Crawley, UK) and 10 mg/ml propidium iodide, incubated at room temperature for 30 min, then analysed using a Beckton Dickinson (Cowley, UK) FACScan flow cytometer. For mitotic index determinations fixed cells were incubated with polyclonal anti-phospho histone H3 antibodies followed by fluorescein isothiocyanate (FITC)-conjugated secondary antibody as described previously (Zachos et al., 2003) . Cells were then counterstained with propidium iodide as above and analysed for FITC fluorescence and DNA content by flow cytometry (Zachos et al., 2003) .
Immunocytochemistry and microscopy Cells were either grown on or allowed to attach to poly-Llysine-coated coverslips, fixed with 3.7% formaldehyde in PBS for 15 min, permeabilized with 0.1% Triton X-100 in PBS for 10 min and blocked with 10% fetal calf serum, 0.5% bovine serum albumin in PBS for 30 min. Anti-phospho histone H3 (rabbit polyclonal, Chemicon, Millipore, Watford, UK, 06-570) and anti-phospho H2AX (g-H2AX; mouse monoclonal, Chemicon, 05-636) were diluted 1 in 100 in blocking buffer. Cells were incubated with the antibodies for 60 min and then washed 3 Â 5 min in blocking buffer. Antirabbit-TRITC (Stratech Scientific Ltd, Luton, UK, 111-025-144) and anti-mouse-FITC (Stratech Scientific, were each used at 1 in 100 dilution in blocking buffer. Cells were incubated with the secondary antibodies for 60 min, washed 2 Â 5 min with blocking buffer and 1 Â 5 min with PBS before being mounted in vectashield. Cells were viewed using a Leica DMIRE2 confocal microscope. At least 120 mitotic cells were scored for each genotype per experiment.
For cytological analysis of chromosomes, cells were treated with 0.1 mg/ml colcemid (Sigma, D 1925) for 120 min before harvesting by centrifugation. Cells were resuspended in 0.9% sodium citrate and incubated at room temperature for 15 min. Cells were then collected by centrifugation and fixed with freshly prepared methanol:acetic acid (3:1) solution. Cells were dropped from a height of approximately 30 cm onto glass slides at an angle of 30-451. The slides were air dried at room temperature for several days before being stained with Giemsa solution for 10-20 min. After drying overnight or at 501C for 20 min the cells were mounted in Hystomount. Photographs of individual metaphase spreads were taken using a Zeiss Axioskop 50 manual microscope with AxioCam HR colour digital camera. At least 40 metaphase spreads were scored for each genotype per experiment.
